baber/WOPTO huggingface dataset:
Patent CA-2422828-A1 (CA)
Title: Novel tumor-associated marker
Inventor: KALANTAROV GARY
IPC: G01N33/577
Filed: 2001-09-18
Abstract: The present invention provides monoclonal antibody-producing hybridomas designated 27.F7 and 27.B1. The invention provides a method of detecting TIP -2 antigen bearing cancer cells in a sample. The invention provides a method of  detecting TIP-2 antigen on the surface of cancer cells. The invention provid es a method for diagnosing cancer in a subject. The invention provides a method  for delivering exogenous material to TIP-2 antigen-bearing cancer cells of a  human subject. The invention provides a method for treating cancer in a huma n subject. The invention provides isolated peptides having the amino acid sequences Lys Leu Leu Gly Gly Gln Ile Gly Leu (SEQ. ID NO. ) and Ser Leu Leu  Gly Cys Arg His Tyr Glu Val (SEQ. ID No. ). The invention provides a method for immunohistochemical screening of a tissue section for the presence of TI P- 2 antigen bearing cancer cells. The invention provides a kit for detecting t he presence of TIP-2 antigen-bearing cancer cells. The invention provides a method for detecting the presence of TIP-2 antigen. The invention provides a  method for immunohistochemical screening of tissue sections. The invention provides a method for monitoring progression of cancer wherein the cancer cells are TIP-2 antigen-bearing cells. The invention provides a method for diagnosing cancer associated with the expression of TIP-2.
Patent CA-2425412-A1 (CA)
Title: Nanoscale sensor
Inventor: HENDERSON ERIC
IPC: G01Q60/16
Filed: 2001-10-10
Abstract: In the present invention, organic, inorganic, or other molecules or objects that may participate in an interaction event, are physically linked to nanoscale objects, typified, but not limited to, carbon nanotubes, silicon nanotubes, nanobars, and biological structural elements, such as microtubules and actin filaments, to create a signal transduction system that reports events on the micron scale or smaller. A molecular interaction even is monitored utilizing an amp meter or utilizing a scanning tunneling microscope so that when the molecules or objects participate in a molecule interaction event, or some other interaction event, the movement or change in the physical properties of the nanotube is monitored to report the occurrence of the interaction event.
Patent CA-2426278-A1 (CA)
Inventor: BERTHIAUME GILLES
IPC: A47C1/12
Filed: 2003-04-22
Abstract: A foldable seating structure includes a foldable frame defining a first frame section and a second frame section. The first and second frame sections are coupled together by a section hinge allowing the first and second frame sections to pivot relative to one another between a frame deployed configuration and a frame folded configuration wherein in the frame deployed configuration the first and second frame sections are in a substantially horizontal position and in a substantially co-linear relationship relative to each other and wherein in the frame folded configuration the first and second frame sections are in a substantially vertical position and in a substantially parallel and adjacent relationship relative to each other.
Patent CA-2430139-A1 (CA)
Title: Stable, aerosolizable suspensions of proteins in ethanol
Inventor: COWAN SIU MAN L
IPC: A61K9/00
Filed: 2001-11-30
Abstract: Stable suspensions of a biologically active protein are disclosed that are suited for aerosol delivery to the lungs of a patient in need of treatment, which comprise particles of biologically active protein suspended in ethanol.  In a preferred embodiment, the invention describes a stable suspension of insulin useful for aerosol delivery to the lungs of a patient in need of treatment comprising particles of a pharmaceutically effective amount of insulin suspended in ethanol. A method of delivering a therapeutically effective amount of a protein to the respiratory tract Of a patient is described which comprises producing an aerosol of a stable liquid suspension of a protein using an electrohydrodynamic spraying means wherein the liquid suspension comprises particles of the protein suspended in ethanol. The stable ethanol suspensions of the invention may optionally contain up to about 20 %  (V/V) of a pharmaceutically acceptable formulation additive such as glycerol, propylene glycol and polyethylene glycol as well as minor amounts (from about 0.05 % to about 5.0 % (W/V) of a pharmaceutically acceptable excipient.
Patent CA-2432597-A1 (CA)
Title: Transactions between vendors and customers using push/pull platform
Inventor: BATACHIA LEON
IPC: G06Q30/06
Filed: 2001-12-21
Abstract: An ofter and acceptance method and apparatus where the vendor generates offer package for customer acceptance. The offer packages may be created and sent towards a customer (customers) according with a particular policy.
Patent CA-2433286-A1 (CA)
Title: Dispositifs de deviation
Inventor: SAINT-PERE PHILIPPE
IPC: B63B21/66
Filed: 2001-12-12
Abstract: L'invention concerne un dispositif de déviation (22) à utiliser avec un câble de remorquage entre un navire sismique et une remorque, en particulier une flûte sismique ou un réseau de flûtes, laquelle remorque est tractée sous l'eau derrière le navire. Ce dispositif comprend un corps aliforme (28) orienté verticalement, conçu pour produire, en service, une force latérale qui pousse le câble de remorquage latéralement par rapport au sens de déplacement du navire remorqueur. Ce corps aliforme (28) comporte un ou plusieurs éléments de poussée hydrostatique et un bras (32) s'étendant vers l'arrière. Une surface de commande pivotable (54), qui s'étend latéralement du bras (32), est conçue pour produire, en service, une force présentant une composante sensiblement verticale. L'angle de la surface de commande peut être commandé à distance, ce qui permet de contrôler la profondeur du dispositif de déviation.
Patent CA-2433806-A1 (CA)
Inventor: BLANCO PATRICK
IPC: A61P25/00
Filed: 2002-01-08
Abstract: The invention provides a method for treating an autoimmune disease in a subject by administering an interferon antagonist and a Flt3 ligand (Flt3L) antagonist. The invention also provides compositions containing one or more interferon antagonists, and one or more Flt3L antagonists, an in vitro assay for determining a subject's risk for developing an autoimmune disease, and kits for use, inter alia, with the assay.
Patent CA-2433933-A1 (CA)
Inventor: NOBLITT TIMOTHY WAYNE
IPC: A61K38/19
Filed: 2002-02-14
Abstract: The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders.  More specifically the present invention relates to methods of using compositions comprising at least one LP82 agonist, LP82 antagonist, LP82 polynucleotide, LP82 polypeptide, and/or LP82 antibody for the prevention and/or treatment of mammalian hematopoietic disorders, including, but not limited to, anemia, leukemia, and hematopoietic conditions caused by bone marrow transplantation or chemo-/radiation therapy.
Patent CA-2434313-A1 (CA)
Title: Atrial defibrillator, lead systems, and method
Inventor: ALFERNESS CLIFTON A
IPC: A61N1/05
Filed: 1992-04-07
Abstract: An implantable atrial cardioverter is arranged to be powered by a depletable power source for delivering electrical energy to the atria of a human heart in need of cardiversion. The atrial cardioverter comprises: sensing means for sensing electrical activations of the heart, the sensing means being continuously operable. Means are provided, responsive to the sensing means, for determining the time intervals between said sensed electrical activations. The cardioverter also comprises atrial arrhythmia detector means for detecting the presence of an atrial arrhythmia of the heart, disable means for maintaining the atrial arrhythmia detector means normally disabled to avoid excessive consumption of the depeletable power source, and enable means for enabling said atrial arrhythmia detector means responsive to the determined time intervals. Delivery means are provided, responsive to the atrial arrhythmia detector means for delivering the electrical energy to the atria of the heart in response to the atrial arrhythmia detector means detecting atrial arrhythmia of the heart.
Patent CA-2438243-A1 (CA)
Inventor: IKEDA NAOKI
IPC: H01M50/417
Filed: 2002-02-15
Abstract: A successive biaxial-orientation process which comprises extruding a molten polypropylene resin composition containing a nucleating agent of .beta.-crystal through a T-die, cooling the extruded melt on a chill roll, stretching the obtained raw sheet in the lengthwise direction, and then stretching the resulting sheet in the widthwise direction to thereby obtain a biaxially oriented film, wherein the degree of orientation of .beta.-crystal of the lengthwise stretched sheet is adjusted to less than 0.3 by the following process (I) and/or the process (II) and the resulting sheet is annealed at need and then stretched in the widthwise direction: Process (I) of melting a polypropylene resin composition containing needle crystals of a specified nucleating agent of .beta.-crystal at such a temperature that is the melting point of the polypropylene resin or above and lower than the lowest temperature at which the nucleating agent can be dissolved in the polypropylene resin and then extruding the resulting resin composition through a T-die at the temperature, and Process (II) of adjusting the neck-in in the lengthwise stretching to 25 to 55 %. The obtained porous polypropylene films are excellent in breakage resistance in manufacturing and thickness uniformity, have high void contents and high air permeability, and are suitable for battery separators.
Patent CA-2439860-A1 (CA)
Inventor: BETTEGA ERIC
IPC: H01M50/528
Filed: 2002-03-04
Abstract: Un dispositif de raccordement pour un accumulateur 10 électrique un premier sous-ensemble de connexion 16 associé à l'une ékectrides 12. Il compore une lame 20 métallique et conductrice équipée d'une pluralité de picots destinés à s'incruster dans l'électrode 12 pour établir le contact électrique, et des moyens de protection thermique et/ou électrique logés dans un module 25 fixé et connecté électriquement à l'une des extrémités de la lame 20.
Patent CA-2441393-A1 (CA)
Inventor: SCHULTES BIRGIT C
IPC: C07K16/42
Filed: 2002-03-08
Abstract: L'invention concerne des méthodes et des compositions thérapeutiques permettant de modifier l'immunogénicité de l'hôte.
Patent CA-2444521-A1 (CA)
Title: Location-based services
Inventor: BURGISS MICHAEL J
IPC: G06F40/00
Filed: 2002-04-26
Abstract: The present invention discloses a method and system for providing location-based services to a remote terminal (12) that is connected to various types of communication systems (14, 32, 36). A tailored request for information is generated with the remote terminal. In addition, a geographic indicator associated with the remote terminal is also generated in the preferred embodiment.
Patent CA-2448286-A1 (CA)
Inventor: MILLER DOUGLAS K
IPC: A23K1/18
Filed: 2003-11-03
Abstract: The invention provides alfalfa plants with detectable levels of tannins, especially condensed tannins, and methods of making alfalfa plants with detectable levels of tannins. Plants and plant parts of the invention are useful as forage for ruminants as they reduce the risk of bloat and reduce or eliminate the need for protein supplementation in ruminant diets.
Patent CA-2450970-A1 (CA)
Title: Bale unloading arrangement of a large round baler
Inventor: VIAUD JEAN
IPC: A01F15/08
Filed: 2003-11-26
Abstract: A bale unloading arrangement of a large round baler includes a bale take-up device mounted to a carrier which is in turn mounted to the axle of the baler for vertical pivoting movement beneath the baling chamber of the baler. A spring is mounted between the carrier and the axle for keeping the carrier in an elevated position until a completed bale is discharged onto the carrier. The carrier is shaped such that the bale take-up device, which is mounted for movement along the carrier, moves down the carrier to the rear and into a position for gently depositing the bale on the ground. The bale take-up device includes an upper bale-receiving structure that may be selectively pivoted about a fore-and-aft axis so as to deposit a bale on its end, and the carrier is mounted for being shifted sideways so that a bale deposited in this manner may be deposited outside the path traveled by the baler.
Patent CA-2455905-A1 (CA)
Title: Substrat d'impression textile
Inventor: LI SHULONG
IPC: D06P5/00
Filed: 2002-08-27
Abstract: L'invention concerne un substrat textile traité à l'aide d'une composition contenant un agent pour le traitement subséquent des teintures et un agent récepteur à l'encre, pour l'impression ultérieure à l'aide d'une imprimante à jet d'encre. L'agent pour le traitement subséquent des teintures comprend un composé amino réactif se fixant chimiquement au substrat textile. Un liant à base de résine peut également être utilisé lorsque l'agent pour le traitement subséquent des teintures ne se fixe pas de façon adéquate au substrat textile, le liant à base de résine se fixant au substrat textile et l'agent de traitement subséquent des teintures pouvant se fixer au liant à base de résine. L'agent récepteur à l'encre comprend des particules inorganiques telles que l'alumine de boehmite ou le gel de silice.
Patent CA-2456288-A1 (CA)
Inventor: CAUMONT-BERTRAND KARINE
IPC: C07C69/587
Filed: 2002-08-08
Abstract: The invention concerns novel molecules, their preparation and their uses, in particular in the field of human and veterinary medicine and in cosmetics. The inventive compounds are partly fatty acid derivatives and exhibit advantageous pharmacological and cosmetic properties. The invention also concerns various uses of said compounds, the pharmaceutical compositions containing them and methods for preparing them. The inventive compounds are useful in particular for preventing and/or treating dislipidemiae, cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, certain cancers, dermatological diseases, and in cosmetics for fighting against skin aging and its effects notably against wrinkles and the like.
Patent CA-2457258-A1 (CA)
Title: Seat cushion, and seat apparatus provided with such a seat cushion
Inventor: LIEVESTRO ROBERT
IPC: B64D11/06
Filed: 2004-02-09
Abstract: A seat cushion, in particular for an aircraft seat, provided with: - a first foam body (2); - a second foam body (8) extending below the first foam body (2); - detachable connecting means (7, 8) to connect the first foam body (2) to the second foam body (3); wherein the first foam body is provided with a covering (5) which is fixedly connected to this first foam body (2).
Patent CA-2457740-A1 (CA)
Title: System and method for retransmitting uplink data in a code division multiple access communication system
Inventor: CHOI SUNG-HO
IPC: H04J13/00
Filed: 2004-02-10
Abstract: A CDMA communication system including a Node B, a UE located in a region of the Node B, a neighbor Node B being adjacent to the Node B and having a soft handover region where the neighbor Node B overlaps with the Node B, and an RNC connected to the Node B and the neighbor Node B. When the UE is located in a non-soft handover region in a region of the Node B, it transmits uplink data to the Node B for a predetermined first transmission time interval. When the UE is located in the soft handover region, it transmits the uplink data to the Node B and the neighbor Node B for a predetermined second transmission time interval.
Patent CA-2457965-A1 (CA)
Inventor: GALLET THIERRY
IPC: A61P25/24
Filed: 2002-09-19
Abstract: L'invention concerne un dérivé de pyrimidone représenté par la formule (I) ou un sel de celui-ci, formule dans laquelle X désigne deux atomes d'hydrogène, un atome de soufre, un atome d'oxygène ou un groupe alkyle en C1-2 et un atome d'hydrogène ; Y désigne une liaison, un groupe éthénylène, un groupe éthynylène, un atome d'oxygène, un atome de soufre, un groupe sulfonyle, un groupe sulfoxyde, un groupe carbonyle, un groupe hydroxyiminométhylène, un groupe dioxolane, un atome d'azote éventuellement substitué ; ou un groupe méthylène éventuellement substitué ; R1 désigne un noyau 2, 3 ou 4-pyridine éventuellement substitué ; R2 désigne un groupe C1-6 alkyle éventuel; un groupe C3-6 cycloalkyle, un groupe C1-4 alkythio, un groupe C1-4 alcoxy, un groupe C1-2 alkyle perhalogéné, un groupe C1-3 alkyle halogéné, un groupe phénylthio, un groupe benzyle, un noyau benzénique, un noyau indane, un noyau 5, 6, 7, 8-tétrahydronaphtalénique, un noyau naphtalène, un noyau pyridine, un noyau pyrrole, un noyau thiophène, un noyau furanne ou un noyau imidazole ; R3 et R4 désignent chacun, indépendamment, un atome d'hydrogène,un groupe  C1-6 alkyle, un groupe hydroxy, un groupe C1-4 alcoxy ou un atome d'halogène ; R5 désigne un atome d'hydrogène, un groupe C1-6 alkyle ou un atome d'halogène ; à condition que lorsque R3 et R4 désignent chacun un atome d'hydrogène, R5 n'est pas un atome d'hydrogène. L'invention concerne en outre un médicament comprenant le dérivé précité ou un sel de celui-ci, comme ingrédient actif, utilisé pour le traitement préventif et/ou thérapeutique d'une maladie neurodégénérative causée par une activité anormale de GSK3 beta  ou de GSK3 beta  et de cdk5/p25, telle que la maladie d'alzheimer.
Patent CA-2460478-A1 (CA)
Title: Failure detection device for vehicle with deceleration deactivatable engine
Inventor: NAKAMOTO YASUO
IPC: B60W10/18
Filed: 2002-09-13
Abstract: A trouble detector of a vehicle having a deceleration idling-cylinder engine capable of idling a part of the cylinders by allowing the hydraulic pressure of hydraulic oil to close both an intake valve and an exhaust valve and releasing the closed state of both the intake valve and the exhaust valve by allowing the hydraulic pressure of the hydraulic oil to relatively act on th e cylinder idling releasing side route, characterized by comprising a hydrauli c pressure condition determination means for determining whether or not an output value from a POIL sensor for detecting a hydraulic pressure in a cylinder idling releasing side route can meet the requirements of the thresholds of the hydraulic pressure of the hydraulic oil in each operating state of the vehicle (Steps S204, S212) and an abnormality determination mea ns for determining to be abnormal when the hydraulic pressure of the hydraulic oil is determined not to meet the requirements of the thresholds of the hydraulic pressure of the hydraulic oil by the hydraulic pressure condition determination means (Steps S207, S215), whereby a trouble can be surely detected by primarily monitoring the hydraulic pressure of the hydraulic oil .
Patent CA-2462299-A1 (CA)
Inventor: VOGELSANG-SWITZER JULIE
IPC: A61B19/00
Filed: 2004-03-29
Abstract: A tray device which goes over and between the legs for raising and supportin g human testes during ultasound inspection, to assist in immobilizing same to improv e ultrasonic imaging, adapted for use when the patient is in a supine position. A pair of spaced-apart downwardly curved members are provided, having a curvature approximating the curvature of a leg of a patient proximate the thigh area. Intermediate each of said curved members is a support member, which is of a narrow width to permit positioning of such support member beneath the testes of a male patient and between the legs of a patient to raise and support such testes to permit ultrasonic examination of such testes. The device may be a unitary one-piece construction, preferably of a moulded plastic , which also facilitates easy sterilization to permit re-use of the device on subsequesnt patients.
Patent CA-2462820-A1 (CA)
Inventor: ZHANG LIN
IPC: B23K9/067
Filed: 2004-03-31
Abstract: Methods and apparatus for initiating an arc (e.g., a welding arc) by directing a beam of electromagnetic radiation at an ionizable chemical placed on the surface of a workpiece, on the torch or some other location in proximity to the gap between the torch and the workpiece. This is done while a potential difference is applied between an electrode of the torch and the workpiece. The radiation vaporizes the chemical to form ionized gas that renders the gap between the electrode and the workpiece more conductive, thereby reducing the voltage threshold needed to initiate an arc between the electrode and the workpiece. When the voltage threshold reaches the level of the applied potential difference, the arc will be initiated.
Patent CA-2464473-A1 (CA)
Title: A rapid serological test for paratuberculosis using fluorescence polarization technology
Inventor: STILWELL KATHRYN IRENE
IPC: C07K14/345
Filed: 2002-10-31
Abstract: The present invention provides an assay for detection of serum antibodies to M. paratuberculosis. A tracer, comprising a carbohydrate antigen isolated fr om M. paratuberculosis that is conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of th e mixture is then measured. The presence of serum antibodies toM. paratuberculosis is indicated by a fluorescence polarization value of the mixture that is higher than the fluorescence polarization value of a control . The present invention further provides a tracer for use in a fluorescence polarization assay for antibodies specific for M. paratuberculosis. The trac er comprises a carbohydrate antigen isolated from M. paratuberculosis and conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for M. paratuberculosis to produce a detectable change i n fluorescence polarization.
Patent CA-2465432-A1 (CA)
Title: Method of manufacturing a stamped biopsy forceps jaw
Inventor: KRZYZANOWSKI JACEK
IPC: A61B10/00
Filed: 2004-04-27
Abstract: A method of progressive die stamping manufacturing a biopsy forceps jaw comprising the steps of cutting a sheet of metal into a strip. The strip of metal may then be punched with a series of guide holes. A shape larger than a pattern of the biopsy forceps jaw may then be defined in the strip of metal. An actuating hole may be punched into the shape. A concave shaped cup portion of the biopsy forceps jaw may be drawn.  The pattern of the biopsy forceps jaw may then be cut to expose a cutting edge and exposed edges of the pattern. The cutting edge can be coined to provide a hardened, sharp, cutting edge. The exposed edges may be chamfered and then the pattern may be folded and shaped to form a biopsy forceps jaw cup and an arm positioned relative to the biopsy forceps jaw cup. A pivot hole may then be punched into the arm. The biopsy forceps jaw may then go through a calibration so that the cutting edge is in a plane perpendicular to a plane of the arm. The jaw cup may then be cut off of the strip of metal.
Patent CA-2467534-A1 (CA)
Title: Data communication apparatus for currency acceptor
Inventor: WIGE RUSSELL A
IPC: G07F17/32
Filed: 2004-05-19
Abstract: This invention provides an enhanced bezel for use with a bill acceptor. The enhanced bezel includes a processor to monitor detailed information about the status of the bill acceptor, and other information related to its operation. The processor displays this information through multiple indicators on the enhanced bezel. The bezel is also configured to include an external communication portal/interface, such as an infrared data communications ("IrDA") interface, to output information to an external personal digital assistant ("PDA") or portable computer device. The external device may be capable of downloading data, and, if appropriate, it may reprogram the bill acceptor, calibrate sensors in the bill acceptor, and perform hardware tests, among other tasks. The bill validator's external communication portal/interface will communicate with the external device through a secure proprietary interface protocol.